Evaluation of Asymmetric Dimethylarginine Levels in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Pulmonary Endarterectomy.

Türer Cabbar A., Değertekin M. M., Şimşek M. A., Özveren O., Güleç S., Yanartaş M., ...Daha Fazla

Heart, lung & circulation, cilt.31, ss.110-118, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.hlc.2021.05.090
  • Dergi Adı: Heart, lung & circulation
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.110-118
  • Anahtar Kelimeler: Asymmetric dimethylarginine, Chronic thromboembolic pulmonary hypertension, Pulmonary endarterectomy, CARDIOVASCULAR RISK, NITRIC-OXIDE, LUNG, ARGININE, BIOLOGY
  • Marmara Üniversitesi Adresli: Evet

Özet

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary embolism, and pulmonary endarterectomy (PEA) is the surgical treatment. Asymmetric dimethylarginine (ADMA) levels are increased in pulmonary hypertension. This study aimed to investigate serum ADMA levels in patients with CTEPH, the effect of PEA on ADMA, and its prognostic value in long-term mortality.